Summary
Overview
Work History
Education
Skills
Websites
Projects
Interests
Timeline
Generic
Yuming Xing

Yuming Xing

Mainz

Summary

Organized Medical Monitor offering 2.5 years of industry expertise.

Compassionate professional skilled in oncological laboratory research. Expert in medical literature review. Highly organized and detail-oriented for accurately completing paperwork and documentation.

Overview

6
6
years of professional experience
11
11
years of post-secondary education
3
3
Languages

Work History

Medical Expert

BioNTech SE
01.2023 - Current
  • Work as Sponsor Medical Monitor for reviewing medical data in clinical trials.
  • Responsible for drafting Medical oversight plans, reviewing all clinical trial related documents including IB, CTP, ICF etc.
  • Maintained strong relationships with healthcare providers by addressing their clinical concerns and providing timely, evidence-based responses.
  • Provided consultation to staff and administration on patient treatment.
  • Thoroughly examined patients and elicited medical history data to use in assessing health and identifying eligibility.
  • Evaluated patient histories, complaints, and current symptoms.
  • Advised on risk management strategies by reviewing safety data from clinical trials, contributing to improved patient wellbeing.
  • Studied disease group benefits, patient selection and treatment options to facilitate general health improvement and illness-specific objectives.

Medical Specialist

Biotellconsulting
01.2018 - 01.2019
  • This CRO( Contract Research Organisation ) company's main business focus on registration services, clinical research and biostatistics for biologically innovative drugs, and the projects it undertakes cover the most representative areas of major biotech drug discovery
  • Cultivate plans and innovative strategies for the launch of various anti-cancer drugs, cardiovascular drugs and other drugs and products and the implementation of advanced medical teams
  • Actively communicate and collaborate with patients, referring physicians and researchers to provide clinical trials
  • Proficient in defining and validating protocols for clinical studies
  • Provides clinical information for Biokerun and Hemay products
  • The support will primarily include addressing unsolicited complex medical inquiries.

Education

M.D. - Translational Oncology

University of Erlangen-Nuremberg
Erlangen
05.2019 - Current

Master of Science - Translational Oncology

The University of Sheffield
Sheffield, United Kingdom
05.2016 - 05.2017

Chinese M.D. Programme Clinical Medicine - undefined

Soochow University
09.2011 - 05.2016

Skills

  • CRISPR/Cas9 Gene Editing
  • Oncology
  • Tumour Microenvirement
  • Lab technique
  • Biotechnology
  • Molecular Biology
  • Protocol development
  • Clinical Data Interpretation
  • Adverse Event Assessment

Projects

Explore signalling pathway crosstalk in pancreatic cancer EMT with CRISPR-based Genome Editing, 2020-01-01, Present, Knockout of PDAC related genes (tumour suppressor genes) Validation with lab techniques mainly in: Western blot, Immunofluorescence, Flow Cytometry, etc. Co-Author of CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer, 2019-01-01, 2021-12-31, Department of Surgery, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU) Kerun CPG2 Phase Ia clinical trial, 2018-01-01, 2019-12-31, Purpose: Evaluation of the safety, pharmacokinetic profile and immunogenicity and for the rescue of high-dose methotrexate treatment toxicity My responsibility: Construction of Trial protocol, Researcher Manuals, Informed consent and chair the project launch meeting Hemay022 Phase I clinical study, 2018-01-01, 2019-12-31, Purpose: To assess the safety, tolerability, pharmacokinetic profile in patients with advanced HER2-positive breast cancer My responsibility: Medical monitoring and revision of trial protocols

Interests

Animal care

Video making

Timeline

Medical Expert

BioNTech SE
01.2023 - Current

M.D. - Translational Oncology

University of Erlangen-Nuremberg
05.2019 - Current

Medical Specialist

Biotellconsulting
01.2018 - 01.2019

Master of Science - Translational Oncology

The University of Sheffield
05.2016 - 05.2017

Chinese M.D. Programme Clinical Medicine - undefined

Soochow University
09.2011 - 05.2016
Yuming Xing